🔎 Trials Near Me

Utama › Hidradenitis Suppurativa › Texas

Kajian klinikal Hidradenitis Suppurativa di Texas

8 kajian untuk Hidradenitis Suppurativa sedang mencari peserta di lokasi di Texas.

Bandar di Texas

Teks kajian rasmi (Bahasa Inggeris)

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  • Center for Clinical Studies-Lee, Webster
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07665437

ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

  • Oruka Therapeutics Investigative Site, Dallas
  • Oruka Therapeutics Investigative Site, Missouri City
  • Oruka Therapeutics Investigative Site, San Antonio
Mengambil pesertaFasa 2
Umur 18 hingga 79 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07783542

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  • Elligo Health Research/The Woodlands Dermatology Associates- Site Number : 8400020, The Woodlands
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07225569

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

  • Investigative Site US021, Bellaire
  • Investigative Site US078, Dallas
  • Investigative Site US010, Dallas
  • dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06855498

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

  • UT Southwestern Medical Center, Department of Dermatology- Site Number : 8400022, Dallas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07170917

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

  • Bellaire Dermatology Associates Bda, Bellaire
  • Texas Dermatology Research Center, Dallas
  • 3A Research Llc West Location, El Paso
Mengambil pesertaFasa 2
Umur 12 hingga 17 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07213973

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

  • The University of Texas MD Anderson Cancer Center, Houston
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 71 · Semua jantina · Dikemas kini 16 Apr 2026 · NCT07123038

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

  • Arlington Research Center, Inc., Arlington
  • Texas Dermatology Research Center, Dallas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mac 2026 · NCT07244263

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.